175 years have elapsed since John Hutchinson introduced the world to his version of an
apparatus that had been in development for nearly two centuries, the spirometer. Though he …

Bronchiolitis obliterans syndrome (BOS) may develop after either lung or haematopoietic
stem cell transplantation (HSCT), with similarities in histopathological features and clinical …

The outcomes of transplantation vary widely by organ. Lung transplantation (LTx) has rather
poor long-term outcome, with a current median post-transplant survival of 6.0 years. 1, 2 …

Chronic graft-versus-host disease (GVHD) can be associated with significant morbidity, in
part because of nonreversible fibrosis, which impacts physical functioning (eye, skin, lung …

BACKGROUND Chronic lung allograft dysfunction (CLAD) is a heterogeneous condition.
Characterization of CLAD phenotypes is essential to enhance the understanding of …

COPD and α-1 antitrypsin deficiency emphysema remain one of the major indications for
lung transplantation. If all other treatment possibilities are exhausted or not possible …

Surveillance after lung transplantation is critical to the detection of acute cellular rejection
(ACR) and prevention of chronic lung allograft dysfunction (CLAD). Therefore, we measured …

Lung transplantation is the optimal treatment for selected patients with end-stage chronic
lung diseases. However, chronic lung allograft dysfunction remains the leading obstacle to …

Chronic lung allograft dysfunction (CLAD) remains the major barrier to long‐term survival
after lung transplantation and improved insight into its underlying immunological …

Background. Telehealth platforms with remote phlebotomy and biomarker implementation
represent a novel paradigm for surveillance after lung transplantation (LT). In a pilot study …